NSE filing, NSE: ROSSARI. Summary written from the filing by ALFA Finder's alert engine.
Rossari Biotech Ltd: key numbers
- Share price
- ₹407.35
- Market cap
- ₹2,256 Cr
- Revenue (annual)
- ₹2,396 Cr
- Net profit (annual)
- ₹149.2 Cr
- P/E (TTM)
- 14.8×Sector 33.6×
- Promoter holding
- 68.14%+0.00% QoQ
- FII holding
- 1.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rossari Biotech Ltd
All →Rossari Biotech Earnings Call Transcript: Key Takeaways
Rossari Biotech achieved record quarterly revenue and EBITDA despite volatile raw material costs and logistical headwinds.
- Call
- Guides 15% growth
Rossari Biotech Results Update
Rossari Biotech reported Q2 FY27 revenue of Rs. 697.6 crore, up 19% YoY. The company also announced plans for a new manufacturing facility in Saudi Arabia.
Rossari Biotech Investor Presentation: Key Takeaways
Rossari Biotech reported record quarterly revenue of Rs. 697.6 Cr (up 19% YoY) and EBITDA of Rs. 87 Cr (up 21% YoY). Performance driven by volume and product mix.
Rossari Biotech Q2 FY27 Results: Net Profit ₹38.9 Cr, Up 5.4% YoY
Rossari Biotech Ltd reported revenue from operations of ₹697.6 Cr (+19.0% YoY) and net profit of ₹38.9 Cr (+5.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹38.9 Cr · +5.4% YoY
Rossari Biotech Other Announcement
Rossari Biotech submitted its quarterly shareholding pattern for the period ended September 30, 2026. The filing includes minor reporting adjustments for two promoter group members.
Rossari Biotech Board Meeting Date
Rossari Biotech will hold a board meeting on October 17, 2026, to consider and approve its unaudited financial results for the quarter ending September 30, 2026.
Other employee stock options announcements
All →CG Power and Industrial Solutions Employee Stock Options
CG Power allotted 17,000 equity shares to an employee under its ESOP 2021 scheme on 3 November 2026. Paid-up capital rises slightly through employee option exercise.
CARE Ratings Employee Stock Options
CARE Ratings allotted 16,133 equity shares to employees on exercising ESOP options under the CARE ESOS 2020. Paid-up capital rises to Rs.30,14,87,450 across 3,01,48,745 shares.
Transport Corporation of India Employee Stock Options
Transport Corporation of India allotted 12,055 equity shares to employees on exercise of ESOP options. This is routine share-based compensation with no cash event value.
TVS Supply Chain Solutions Employee Stock Options
TVS Supply Chain Solutions allotted equity shares to employees under its MIP II and ESOP Scheme 2021. The allotment follows employee exercise of stock options.
Aditya Birla Sun Life AMC Employee Stock Options
Aditya Birla Sun Life AMC allotted 6,400 equity shares under its 2021 ESOP scheme. This allotment increases the company's paid-up equity share capital to ₹144.70 Crore.
Polycab India Employee Stock Options
Polycab India Limited allotted 3,403 equity shares under its Employee Stock Option Scheme 2018. The allotment follows the exercise of options by eligible employees.